Clinical Trials Begin For Pfizer And BioNTech’s Omicron-Specific Covid Shot

1/25/2022 6:48:00 PM

Pfizer and BioNTech have begun a clinical trial for their omicron-specific coronavirus vaccine

Clinical Trials Begin For Pfizer, Biontech

Pfizer and BioNTech have begun a clinical trial for their omicron-specific coronavirus vaccine

I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter @theroberthart or email me at rhart@forbes.com

ToplinePfizer and BioNTech have begun a clinical trial for their omicron-specific coronavirus vaccine, the companies announced Tuesday, as vaccine makers scramble to reformulate shots to target the infectious variant. Pfizer launched clinical trials for its omicron vaccine.

Getty ImagesKey FactsThe study will evaluate the vaccine for safety, tolerability and strength of immune response in up to 1,420 healthy adults ages 18 to 55, the companies said in a statement.The companies will test the vaccine in unvaccinated people as part of a three-shot course, as a booster shot in those who have received two Pfizer-BioNTech doses already and as a fourth dose for people who have already had three Pfizer-BioNTech shots.

Read more: Forbes »

The Real Deal: Tips to help you save on back-to-school clothing

How can you make sure you don’t overspend? News 12's consumer reporter Janice Lieberman has The Real Deal to help you shop smart. Read more >>

Clinical Trials Begin For Pfizer And BioNTech’s Omicron-Specific Covid ShotI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com For every variant u must take a shot 😅🤣😂😹

Pfizer says it's starting clinical studies of an omicron-based COVID-19 vaccine Pfizer and BioNTech said Tuesday they've stated clinical trials for an omicron-based COVID-19 vaccine. No By the time it's ready, omicron will be over.

Pfizer starts clinical trial for omicron-specific Covid vaccineJUST IN: Pfizer and BioNTech announce that they have started a clinical trial testing a modified Covid-19 vaccine to protect against the omicron variant. Honestly, receiving $5,000 within a week from my invested $500 was something i never really expected. Thanks so much crypto__kendra_ for puting a smile on my face with this Bitcoin investment programme. May God continue to bless you. too late another one is coming up New year, new yatch

Pfizer Begins Clinical Trial for Omicron-Specific COVID Vaccine Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant 𝖨𝗍'𝗌 𝗈𝗏𝖾𝗋 6𝗆𝗈𝗇𝗍𝗁𝗌 𝗇𝗈𝗐, 𝗂'𝗆 𝗌𝗍𝗂𝗅𝗅 𝗆𝖺𝗄𝗂𝗇𝗀 𝗀𝗈𝗈𝖽 𝗆𝗈𝗇𝖾𝗒 trading crypto 𝗐𝗂𝗍𝗁 𝗍𝗁𝖾 𝗁𝖾𝗅𝗉 𝗈𝖿 stephinieweller 𝖼𝗈𝗇𝗍𝖺𝖼𝗍 her now and enjoy crypto trading with good profits, stephinieweller

Pfizer Begins Clinical Trial For Omicron-Targeting Vaccine Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant. Jesus Christ people... Liberals love themselves some Pfizer. This news will be like Christmas to them. spare a thought for all the animals sacrificed for humans more than likely, they lived and died painfully when will we evolve? vivisection

Pfizer CEO sees annual COVID vaccine rather than frequent boosters Pfizer Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.

Share to Linkedin Topline Pfizer and BioNTech have begun a clinical trial for their omicron-specific coronavirus vaccine, the companies announced Tuesday, as vaccine makers scramble to reformulate shots to target the infectious variant.Share to Linkedin Topline Pfizer and BioNTech have begun a clinical trial for their omicron-specific coronavirus vaccine, the companies announced Tuesday, as vaccine makers scramble to reformulate shots to target the infectious variant.Pfizer and BioNTech said Tuesday they've begun clinical trials for an omicron-based COVID-19 vaccine.Jan.

  Pfizer launched clinical trials for its omicron vaccine. Getty Images Key Facts The study will evaluate the vaccine for safety, tolerability and strength of immune response in up to 1,420 healthy adults ages 18 to 55, the companies said in a statement. Getty Images Key Facts The study will evaluate the vaccine for safety, tolerability and strength of immune response in up to 1,420 healthy adults ages 18 to 55, the companies said in a statement. The companies will test the vaccine in unvaccinated people as part of a three-shot course, as a booster shot in those who have received two Pfizer-BioNTech doses already and as a fourth dose for people who have already had three Pfizer-BioNTech shots. Jansen, Pfizer's senior vice president and head of vaccine research and development. The trial will compare between a fourth dose of the omicron-specific vaccine and a fourth dose of the original vaccine. This is a developing story.  The companies said they do not expect manufacturing capacity—an estimated four billion doses in 2022—to change if they pivot to an omicron-specific shot."If it happens, the new variant would kill a lot of vaccinated people and change the face of the pandemic for the worse.

  Key Background .S.